A 3-month lifestyle modification program resulted in weight loss and improvement in eating habits, physical activity level, and A1c in patients at risk for type 2 diabetes.
Patients who underwent Roux-en-Y gastric bypass experienced greater weight loss and slightly higher diabetes remission rates than patients who underwent sleeve gastrectomy.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
Menopause is linked to unfavorable health effects in women with type 2 diabetes, but older age at menarche may be associated with a decrease in these adverse effects.
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.
